SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3asi'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FBY_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
6 / 12 ILE A 905
GLN A 895
PHE A 896
LEU A1016
ALA A1017
HIS A 926
None
1.24A 1fbyA-3asiA:
undetectable
1fbyA-3asiA:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHF_A_ACTA507_0
(CHORISMATE SYNTHASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
3 / 3 LEU A 931
ASN A 982
ARG A 958
None
0.81A 2qhfA-3asiA:
undetectable
2qhfA-3asiA:
21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DRC_A_MTXA161_1
(DIHYDROFOLATE
REDUCTASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 ILE A1170
ASP A1192
SER A1231
ILE A1117
LEU A1143
None
1.02A 3drcA-3asiA:
undetectable
3drcA-3asiA:
15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SFU_A_RBVA601_1
(RNA POLYMERASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 9 ASP A 930
ASN A 913
GLY A 912
ASP A 914
ASP A 911
None
1.47A 3sfuA-3asiA:
undetectable
3sfuA-3asiA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3N_A_MIYA2001_1
(TETX2 PROTEIN)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 11 GLN A1064
PHE A1068
GLY A1067
GLY A1059
ASN A1083
None
1.31A 3v3nA-3asiA:
undetectable
3v3nA-3asiA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3N_D_MIYD2001_1
(TETX2 PROTEIN)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 11 GLN A1064
PHE A1068
GLY A1067
GLY A1059
ASN A1083
None
1.31A 3v3nD-3asiA:
undetectable
3v3nD-3asiA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_B_T1CB405_1
(TETX2 PROTEIN)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 GLN A1064
PHE A1068
GLY A1067
GLY A1059
ASN A1083
None
1.27A 3v3oB-3asiA:
undetectable
3v3oB-3asiA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WDM_A_ADNA901_1
(4-PHOSPHOPANTOATE--B
ETA-ALANINE LIGASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 9 GLY A 910
LEU A 983
ASN A 913
ASN A 908
ILE A 916
None
1.40A 3wdmA-3asiA:
undetectable
3wdmA-3asiA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WDM_A_ADNA901_1
(4-PHOSPHOPANTOATE--B
ETA-ALANINE LIGASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 9 GLY A 910
LEU A 983
ASP A 930
ASN A 913
ILE A 916
None
1.21A 3wdmA-3asiA:
undetectable
3wdmA-3asiA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WDM_C_ADNC301_1
(4-PHOSPHOPANTOATE--B
ETA-ALANINE LIGASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 9 GLY A 910
LEU A 983
ASP A 930
ASN A 913
ILE A 916
None
1.17A 3wdmC-3asiA:
undetectable
3wdmC-3asiA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_A_T1CA392_1
(TETX2 PROTEIN)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 11 GLN A1064
PHE A1068
GLY A1067
GLY A1059
ASN A1083
None
1.22A 4a6nA-3asiA:
undetectable
4a6nA-3asiA:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_D_MIYD391_1
(TETX2 PROTEIN)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 11 GLN A1064
PHE A1068
GLY A1067
GLY A1059
ASN A1083
None
1.38A 4a99D-3asiA:
undetectable
4a99D-3asiA:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DFR_A_MTXA161_1
(DIHYDROFOLATE
REDUCTASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 ILE A1170
ASP A1192
SER A1231
ILE A1117
LEU A1143
None
1.02A 4dfrA-3asiA:
undetectable
4dfrA-3asiA:
16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MMC_A_29JA604_1
(TRANSPORTER)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
4 / 7 ARG A1258
ILE A1098
PHE A1091
LEU A1241
None
0.89A 4mmcA-3asiA:
undetectable
4mmcA-3asiA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NQA_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
6 / 11 ILE A 905
GLN A 895
PHE A 896
LEU A1016
ALA A1017
HIS A 926
None
1.32A 4nqaA-3asiA:
undetectable
4nqaA-3asiA:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NQA_H_9CRH501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 ILE A 905
GLN A 895
LEU A1016
ALA A1017
HIS A 926
None
1.06A 4nqaH-3asiA:
undetectable
4nqaH-3asiA:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_1
(PROTEASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 GLY A1118
ILE A1217
VAL A1152
VAL A1240
ILE A1215
None
0.97A 4q5mA-3asiA:
undetectable
4q5mA-3asiA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QI9_A_MTXA201_1
(DIHYDROFOLATE
REDUCTASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 ILE A1170
ASP A1192
SER A1231
ILE A1117
LEU A1143
None
0.97A 4qi9A-3asiA:
undetectable
4qi9A-3asiA:
18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QI9_B_MTXB201_1
(DIHYDROFOLATE
REDUCTASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 ILE A1170
ASP A1192
SER A1231
ILE A1117
LEU A1143
None
1.04A 4qi9B-3asiA:
undetectable
4qi9B-3asiA:
18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QLE_B_FOLB201_0
(DIHYDROFOLATE
REDUCTASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 11 ILE A1170
ASP A1192
SER A1231
ILE A1117
LEU A1143
None
1.04A 4qleB-3asiA:
undetectable
4qleB-3asiA:
14.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YP2_B_NCAB302_0
(RIBOSOME-INACTIVATIN
G PROTEIN MOMORDIN I)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 9 ILE A1098
PHE A1091
GLY A1096
ILE A1253
ALA A1252
None
1.38A 4yp2B-3asiA:
undetectable
4yp2B-3asiA:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CF9_B_NCAB302_0
(RIBOSOME-INACTIVATIN
G PROTEIN MOMORDIN I)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 9 ILE A1098
PHE A1091
GLY A1096
ILE A1253
ALA A1252
None
1.39A 5cf9B-3asiA:
undetectable
5cf9B-3asiA:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI6_A_MTXA201_1
(DIHYDROFOLATE
REDUCTASE)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
5 / 12 ILE A1170
ASP A1192
SER A1231
ILE A1117
LEU A1143
None
0.99A 5hi6A-3asiA:
undetectable
5hi6A-3asiA:
16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HRQ_E_IPHE101_0
(INSULIN A-CHAIN
INSULIN B-CHAIN)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
4 / 7 ILE A1170
HIS A1144
LEU A1128
ALA A1126
None
0.87A 5hrqE-3asiA:
undetectable
5hrqF-3asiA:
undetectable
5hrqJ-3asiA:
undetectable
5hrqE-3asiA:
4.32
5hrqF-3asiA:
8.37
5hrqJ-3asiA:
8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1B_C_CHDC304_0
(CYTOCHROME C OXIDASE
SUBUNIT 3)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
3 / 3 ARG A1024
PHE A 894
LEU A 989
None
0.56A 5x1bC-3asiA:
undetectable
5x1bC-3asiA:
18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DHB_A_BEZA202_0
(HEPATITIS A VIRUS
CELLULAR RECEPTOR 2)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
4 / 6 PHE A1209
ARG A1182
ASN A1236
ASP A1113
None
1.28A 6dhbA-3asiA:
undetectable
6dhbA-3asiA:
12.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FBN_B_SAMB401_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
3asi NEUREXIN-1-ALPHA
(Bos
taurus)
4 / 7 ALA A1008
GLU A 919
ILE A 905
ILE A 991
None
0.92A 6fbnA-3asiA:
undetectable
6fbnA-3asiA:
22.51